JP2003535864A5 - - Google Patents

Download PDF

Info

Publication number
JP2003535864A5
JP2003535864A5 JP2002501899A JP2002501899A JP2003535864A5 JP 2003535864 A5 JP2003535864 A5 JP 2003535864A5 JP 2002501899 A JP2002501899 A JP 2002501899A JP 2002501899 A JP2002501899 A JP 2002501899A JP 2003535864 A5 JP2003535864 A5 JP 2003535864A5
Authority
JP
Japan
Prior art keywords
group
hydroxy
unsubstituted
alkylamino
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002501899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003535864A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/006306 external-priority patent/WO2001094350A1/en
Publication of JP2003535864A publication Critical patent/JP2003535864A/ja
Publication of JP2003535864A5 publication Critical patent/JP2003535864A5/ja
Withdrawn legal-status Critical Current

Links

JP2002501899A 2000-06-07 2001-06-01 6−フェニルピロロピリミジンジオン誘導体 Withdrawn JP2003535864A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200001436 2000-06-07
ES200001436 2000-06-07
PCT/EP2001/006306 WO2001094350A1 (en) 2000-06-07 2001-06-01 6-phenylpyrrolopyrimidinedione derivatives

Publications (2)

Publication Number Publication Date
JP2003535864A JP2003535864A (ja) 2003-12-02
JP2003535864A5 true JP2003535864A5 (enExample) 2008-07-17

Family

ID=8493813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002501899A Withdrawn JP2003535864A (ja) 2000-06-07 2001-06-01 6−フェニルピロロピリミジンジオン誘導体

Country Status (12)

Country Link
US (1) US6943253B2 (enExample)
EP (1) EP1286997B1 (enExample)
JP (1) JP2003535864A (enExample)
AR (1) AR030424A1 (enExample)
AT (1) ATE273980T1 (enExample)
AU (1) AU2001281802A1 (enExample)
CA (1) CA2411013A1 (enExample)
DE (1) DE60105020T2 (enExample)
ES (1) ES2222389T3 (enExample)
MY (1) MY133995A (enExample)
PE (1) PE20020219A1 (enExample)
WO (1) WO2001094350A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2193839B1 (es) * 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
ES2208063B1 (es) 2002-04-01 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de la 4-(pirrolopirimidin-6-il)bencenosulfonamida.
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
US20070010450A1 (en) 2003-06-13 2007-01-11 Microbia, Inc., A Massachusetts Corporation Methods and compositions for the treatment of gastrointestinal disorders
CN1890241A (zh) 2003-10-31 2007-01-03 Cv医药有限公司 A2b腺苷受体拮抗剂
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077898A1 (es) * 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
AT512084A1 (de) * 2011-10-20 2013-05-15 Univ Wien Tech Diazabicyclo- und diazaspiro-alkanderivate als phosphodiesterase-5 inhibitoren
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
TWI698436B (zh) 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
MA41291A (fr) 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
HK1248221A1 (zh) 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 异噻唑啉酮类,吡唑并嘧啶酮类和吡咯并嘧啶酮作为泛蛋白特异性蛋白酶7抑制剂
HK1248220A1 (zh) 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 喹唑啉酮和偶氮喹唑啉作为泛特丁胺蛋白酶7抑制剂
HK1248222A1 (zh) 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 噻吩并嘧啶酮作为泛素特异性蛋白酶7抑制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260322A (en) 1990-10-08 1993-11-09 Merck & Co., Inc. Angiotension II antagonists in the treatment of hyperuricemia
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
AU4501199A (en) * 1998-06-03 1999-12-20 Almirall Prodesfarma S.A. 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors

Similar Documents

Publication Publication Date Title
AU2011257336B2 (en) The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
ES2232502T3 (es) Derivados de pirazolo(4,3-d)pirimidina.
RU2002104935A (ru) ПРОИЗВОДНЫЕ 8-ФЕНИЛ-6,9-ДИГИДРО[1,2,4]ТРИАЗОЛО[3,4-i]ПУРИН-5-ОНА
US6218397B1 (en) Pyrazolopyrimidines as CRF antagonists
JP3727525B2 (ja) 医薬として活性のある化合物
US9783552B2 (en) Soluble guanylate cyclase activators
RU2004139111A (ru) Новые конденсированные производные имидазола
NZ503703A (en) use of corticotropin release factor antagonist to treat sudden death by improving the QT dispersion and heart rate variability
RU2002134487A (ru) Бензофены как ингибиторы il-1бета и tnf-альфа
RU2017112518A (ru) Пиридоновые и азапиридоновые соединения и способы применения
RU2006105716A (ru) Производные пиридазина и их применение в качестве терапевтических средств
RU2009101298A (ru) Гетероциклические соединения в качестве усилителей подслащивающего вещества
TW200500364A (en) Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
JP2003525279A5 (enExample)
JP2008545783A5 (enExample)
RU2013104520A (ru) Пирролопиримидиновые соединения и их применения
NZ314110A (en) The use of pyrazolopyrimidinone derivatives in preparing pharmaceutical compositions
WO2000042026B1 (en) Non-peptide glp-1 agonists
RU2004106783A (ru) Производные 4-амино-6-фенилпирроло[2, 3] пиримидина
HUP9904434A2 (hu) Pirazolo[4,3-d]pirimidinon-, kinazolinon-, purinon- és pirido[3,2-d]pirimidinon-származékok alkalmazása nitrát-indukált tolerancia kezelésére szolgáló gyógyszerkészítmények előállítására
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
ZA200508158B (en) Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
JP2022514650A5 (enExample)
RU2015102537A (ru) Цианогуанидины и их применение в качестве противовирусных средств
WO2008136377A1 (ja) 二環式複素環化合物